77 related articles for article (PubMed ID: 7718313)
1. Networks controlling pneumocyte proliferation. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia.
Richards RJ
Hum Exp Toxicol; 1994 Dec; 13(12):909-10. PubMed ID: 7718313
[No Abstract] [Full Text] [Related]
2. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia.
Sunday ME; Willett CG; Patidar K; Graham SA
Lab Invest; 1994 Jun; 70(6):875-88. PubMed ID: 8015292
[TBL] [Abstract][Full Text] [Related]
3. Induction and spontaneous regression of pulmonary neuroendocrine cell hyperplasia in a hamster model.
Sunday ME; Willett CG
Chest; 1992 Mar; 101(3 Suppl):21S. PubMed ID: 1541190
[No Abstract] [Full Text] [Related]
4. CD10/neutral endopeptidase inhibition augments pulmonary neuroendocrine cell hyperplasia in hamsters treated with diethylnitrosamine and hyperoxia.
Willett CG; Shahsafei A; Graham SA; Sunday ME
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):13-20. PubMed ID: 10385588
[TBL] [Abstract][Full Text] [Related]
5. Induction and spontaneous regression of intense pulmonary neuroendocrine cell differentiation in a model of preneoplastic lung injury.
Sunday ME; Willett CG
Cancer Res; 1992 May; 52(9 Suppl):2677s-2686s. PubMed ID: 1314133
[TBL] [Abstract][Full Text] [Related]
6. An animal model for neuroendocrine lung cancer.
Schuller HM; Becker KL; Witschi HP
Carcinogenesis; 1988 Feb; 9(2):293-6. PubMed ID: 3338113
[TBL] [Abstract][Full Text] [Related]
7. Effects of fibres on cell proliferation, cell activation and gene expression.
Driscoll KE
IARC Sci Publ; 1996; (140):73-96. PubMed ID: 9101318
[No Abstract] [Full Text] [Related]
8. Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia.
Schuller HM; Witschi HP; Nylen E; Joshi PA; Correa E; Becker KL
Cancer Res; 1990 Mar; 50(6):1960-5. PubMed ID: 2306745
[TBL] [Abstract][Full Text] [Related]
9. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
10. Induction of stable p53 oncoprotein and of c-myc overexpression in cultured normal human uroepithelium by radiation and N-nitrosodiethanolamine.
Mothersill C; Harney J; Seymour CB
Radiat Res; 1994 Apr; 138(1):93-8. PubMed ID: 8146306
[TBL] [Abstract][Full Text] [Related]
11. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
12. High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells.
Cohen AJ; King TE; Gilman LB; Magill-Solc C; Miller YE
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1593-9. PubMed ID: 9817713
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin as a marker for diethylnitrosamine-induced pulmonary endocrine cell hyperplasia in hamsters.
Linnoila RI; Becker KL; Silva OL; Snider RH; Moore CF
Lab Invest; 1984 Jul; 51(1):39-45. PubMed ID: 6737995
[TBL] [Abstract][Full Text] [Related]
14. Diffuse idiopathic pulmonary neuroendocrine cell proliferation presenting as interstitial lung disease.
Armas OA; White DA; Erlandson RA; Rosai J
Am J Surg Pathol; 1995 Aug; 19(8):963-70. PubMed ID: 7611544
[TBL] [Abstract][Full Text] [Related]
15. Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line.
Negroni A; Scarpa S; Romeo A; Ferrari S; Modesti A; Raschellà G
Cell Growth Differ; 1991 Oct; 2(10):511-8. PubMed ID: 1751406
[TBL] [Abstract][Full Text] [Related]
16. Changes in expression of onco- and suppressor genes in peripheral leukocytes--as potential biomarkers of chemical carcinogenesis.
Gyöngyi Z; Ember I; Kiss I; Varga C
Anticancer Res; 2001; 21(5):3377-80. PubMed ID: 11848497
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
18. Unilateral diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and multiple carcinoids treated with surgical resection.
Irshad S; McLean E; Rankin S; Barrington S; Santis G; Spicer J; Lang-Lazdunski L
J Thorac Oncol; 2010 Jun; 5(6):921-3. PubMed ID: 20502273
[No Abstract] [Full Text] [Related]
19. Neuroendocrine phenotype differentiation in a hamster lung epithelial cell line under low oxygen pressure or after transformation by diethylnitrosamine.
Emura M; Ochiai A; Gobert-Bohlen A; Panning B; Dungworth DL
Toxicol Lett; 1994 Jun; 72(1-3):59-64. PubMed ID: 8202957
[TBL] [Abstract][Full Text] [Related]
20. Nitrosamine-induced lung carcinogenesis and Ca2+/calmodulin antagonists.
Schüller HM
Cancer Res; 1992 May; 52(9 Suppl):2723s-2726s. PubMed ID: 1314135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
